This compound is a spirocyclic heterocyclic molecule containing a tetrazatricyclic core with a methylsulfanyl substituent and a cyclohexane ring. It is characterized by a combination of aromatic rings, an amide group, and heterocyclic structural elements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-Amino-3-fluoropyridine
pharmaceutical intermediate
Flamenol
Pharmaceutical intermediate
Sodium camphorsulfonate
research compound
2,3,4,5,6,7-Hexamethyl-1H-indene
Research compound
Trilaciclib Impurity 36
pharmaceutical intermediate
Trilaciclib Impurity 3
pharmaceutical intermediate
Tert-butyl 4-methylsulfanyl-10-oxospiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
Tert-butyl 8-hydroxy-4-methylsulfanyl-10-oxo-spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-11-carboxylate
pharmaceutical intermediate
4-methylsulfanylspiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one
MORDOLIVMBQSKA-UHFFFAOYSA-N
CSC1=NC=C2C=C3C(=O)NCC4(N3C2=N1)CCCCC4
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.